dm+d

21938911000001104

Articles

Insulin preparations: RMOC recommendations of safety considerations for formulary decision making

22 June 2018At its meeting on 18th April 2018 the Regional Medicines Optimisation Committee (RMOC) (Midlands and East) reviewed issues pertaining to safety considerations when adopting any…
Search Articles

New Medicines

TresibaType 1 diabetes mellitus in pregnant women

Information

Tresiba
Licence extension / variation
Novo Nordisk
Novo Nordisk

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
None

Category

Neutral soluble long acting insulin given 3 times a week
Approximately 2,625 people with pre-existing type 1 diabetes give birth in England and Wales each year [1].
Type 1 diabetes mellitus in pregnant women
Subcutaneous injection